Guidelines for the diagnosis, investigation and management of polycythaemia/erythrocytosis

British Journal of Haematology

Volumn 130, Issue 2, 2005, Pages 174-195

  McMullin, Mary F ^a,k   Bareford, D ^b   Campbell, P ^c   Green, A R ^c   Harrison, Claire ^d   Hunt, Beverley ^d   Oscier, D ^e   Polkey, M I ^f   Reilly, J T ^g   Rosenthal, E ^h   Ryan, Kate ⁱ   Pearson, T C ^d   Wilkins, Bridget ^j  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b CITY HOSPITAL   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d ST THOMAS HOSPITAL   (United Kingdom)

^e ROYAL BOURNEMOUTH HOSPITAL   (United Kingdom)

^f ROYAL BROMPTON HOSPITAL   (United Kingdom)

^g ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^h GUY S HOSPITAL   (United Kingdom)

ⁱ MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^j ROYAL VICTORIA INFIRMARY   (United Kingdom)

^k British Society for Haematology   (United Kingdom)

more..

Author keywords

Erythrocytosis; Management; Polycythaemia; Polycythaemia vera; Secondary erythrocytosis

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA INTERFERON; ANAGRELIDE; BUSULFAN; CARBOQUONE; CHLORAMBUCIL; CYANOCOBALAMIN; DIPYRIDAMOLE; ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; FERRITIN; HYDROXYUREA; MELPHALAN; PHOSPHORUS 32; PIPOBROMAN; TIOGUANINE; VON HIPPEL LINDAU PROTEIN; ALKYLATING AGENT;

ARTERIAL OXYGEN SATURATION; BLEEDING; BLOOD CELL COUNT; BONE MARROW EXAMINATION; BURST FORMING UNIT E; CLINICAL TRIAL; CYANOTIC HEART DISEASE; DIAGNOSTIC PROCEDURE; DIGESTIVE SYSTEM FUNCTION DISORDER; DISEASE CLASSIFICATION; DRUG MEGADOSE; ERYTHROCYTOSIS; FERRITIN BLOOD LEVEL; GENE MUTATION; HEMATOCRIT; HUMAN; HYPOXIA; IDIOPATHIC DISEASE; KARYOTYPE; KIDNEY FUNCTION; LEG ULCER; LIVER FUNCTION; OXYGEN AFFINITY; OXYGEN DISSOCIATION CURVE; PHLEBOTOMY; POLYCYTHEMIA; POLYCYTHEMIA VERA; PRACTICE GUIDELINE; PREGNANCY; PRIORITY JOURNAL; PRURITUS; RISK ASSESSMENT; SHORT SURVEY; SIDE EFFECT; SKIN PIGMENTATION; THROMBOSIS; ULTRASOUND; VITAMIN BLOOD LEVEL; ANOXIA; ARTICLE; FEMALE; PREGNANCY COMPLICATION;

ALKYLATING AGENTS; ANOXIA; BONE MARROW EXAMINATION; FEMALE; HEMORRHAGE; HUMANS; POLYCYTHEMIA; POLYCYTHEMIA VERA; PREGNANCY; PREGNANCY COMPLICATIONS; THROMBOSIS;

EID: 23844552419     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2005.05535.x     Document Type: Short Survey

References (151)

1. Ammash, N. & Warnes, C.A. (1996) Cerebrovascular events in adult patients with cyanotic congenital heart disease. Journal of the American College of Cardiology, 28, 768-772.
2. Anagrelide Study Group (1992) Anagrelide, a therapy for thrombocythemic states: experience in 577 patients. The American Journal of Medicine, 92, 69-76.
3. Baglin, T., Luddington, R., Brown, K. & Baglin, C. (2003) Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study. Lancet, 362, 523-526.
4. Barabas, A.P., Offen, D.N. & Meinhard, E.A. (1973) The arterial complications of polycythaemia vera. The British Journal of Surgery, 60, 183-187.
5. Barenbrock, M., Spieker, C., Rahn, K.H. & Zidek, W. (1993) Therapeutic efficiency of phlebotomy in posttransplant hypertension associated with erythrocytosis. Clinical Nephrology, 40, 241-243.
6. Berk, P.D., Goldberg, J.D., Silverstein, M.N., Weinfeld, A., Donovan, P.B., Ellis, J.T., Landaw, S.A., Laszlo, J., Najean, Y., Pisciotta, A.V. & Wasserman, L.R. (1981) Increased incidence of acute leukemia in polycythemia vera associated with chlorambucil therapy. The New England Journal of Medicine, 304, 441-447.
7. Berk, P.D., Goldberg, J.D., Donovan, P.B., Fruchtman, S.M., Berlin, N.I. & Wasserman, L.R. (1986) Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols. Seminars in Hematology, 23, 132-143.
8. Berk, P.D., Wassermann, L.R., Fruchtman, S.M. & Goldberg, J.T. (1995) Treatment of polycythaemia vera, a summary of clinical trends conducted by the polycythaemia vera sub-group. In: Treatment of Polycythaemia Vera, a Summary of Clinical Trends Conducted by the Polycythaemia Vera Study Group (ed. by L.P. Wasserman & P.D. Berk), pp. 166-194. W.B. Saunders, Philadelphia, PA.
9. Berlin, N.I. (1975) Diagnosis and classification of the polycythemias. Seminars in Hematology, 12, 339-351.
10. Berruyer, M., Francina, A., Ffrench, P., Negrier, C., Boneu, B. & Dechavanne, M. (1994) Increased thrombosis incidence in a family with an inherited protein S deficiency and a high oxygen affinity hemoglobin variant. American Journal of Hematology, 46, 214-217.
11. Berthrong, M. & Sabiston, D.C. Jr (1951) Cerebral lesions in congenital heart disease, a review of autopsies on 162 cases. Bulletins of John Hopkins Hospital, 89, 384-406.
12. Besarab, A., Caro, J., Jarrell, B.E., Francos, G. & Erslev, A.J. (1987) Dynamics of erythropoiesis following renal transplantation. Kidney International, 32, 526-536.
13. Bridges, N.D. (1994) Risk of stroke in adults with cyanotic congenital heart disease. Circulation, 89, 911.
14. Brown, S.M., Gilbert, H.S., Krauss, S. & Wasserman, L.R. (1971) Spurious (relative) polycythemia: a nonexistent disease. The American Journal of Medicine, 50, 200-207.
15. Brox, A.G., Mangel, J., Hanley, J.A., St Louis, G., Mongrain, S. & Gagnon, R.F. (1998) Erythrocytosis after renal transplantation represents an abnormality of insulin-like growth factor-I and its binding proteins. Transplantation, 66, 1053-1058.
16. Budde, U., Schaefer, G., Mueller, N., Egli, H., Dent, J., Ruggeri, Z. & Zimmerman, T. (1984) Acquired von Willebrand's disease in the myeloproliferative syndrome. Blood, 64, 981-985.
17. Burge, P.S., Johnson, W.S. & Prankerd, T.A. (1975) Morbidity and mortality in pseudopolycythaemia. Lancet, 1, 1266-1269.
18. Butler, W.M., Spratling, L., Kark, J.A. & Schoomaker, E.B. (1982) Hemoglobin Osler: report of a new family with exercise studies before and after phlebotomy. American Journal of Hematology, 13, 293-301.
19. Charache, S., Achuff, S., Winslow, R., Adamson, J. & Chervenick, P. (1978) Variability of the homeostatic response to altered p50. Blood, 52, 1156-1162.
20. Chievitz, E. & Thiede, T. (1962) Complications and causes of death in polycythaemia vera. Acta Medica Scandinavica, 172, 513-523.
21. Collaborative Low-dose Aspirin Study in Pregnancy (CLASP) Collaborative Group (1994) CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group. Lancet, 343, 619-629.
22. Constantinidis, K. (1979) Venesection fatalities in polycythaemia secondary to lung hypoxia. The Practitioner, 222, 89-91.
23. Cortelazzo, S., Finazzi, G., Ruggeri, M., Vestri, O., Galli, M., Rodeghiero, F. & Barbui, T. (1995) Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis. The New England Journal of Medicine, 332, 1132-1136.
24. Criner, G.J. (2000) Effects of long-term oxygen therapy on mortality and morbidity. Respiratory Care, 45, 105-118.
25. Crockett, A.J., Cranston, J.M., Moss, J.R. & Alpers, J.H. (2001) Survival on long-term oxygen therapy in chronic airflow limitation: from evidence to outcomes in the routine clinical setting. Internal Medicine Journal, 31, 448-454.
26. Dayton, L.M., McCullougy, R.E., Scheinhorn, D.J. & Weil, J.V. (1975) Symptomatic and puomonary response to acute phlebotomy in secondary polycythemia. Chest, 68, 785-790.
27. Donovan, P.B., Kaplan, M.E., Goldberg, J.D., Tatarsky, I., Najean, Y., Silberstein, E.B., Knospe, W.H., Laszlo, J., Mack, K. & Berk, P.D. (1984) Treatment of polycythemia vera with hydroxyurea. American Journal of Hematology, 17, 329-334.
28. Eisensehr, I. & Noachtar, S. (2001) Haematological aspects of obstructive sleep apnoea. Sleep Medicine Reviews, 5, 207-221.
29. European Organisation for Research on Treatment of Cancer (1981) Treatment of polycythaemia vera by radiophosphorus or busulphan: a randomised trial. "Leukemia and Hematosarcoma" Cooperative Group, European Organisation for Research on Treatment of Cancer (EORTC). British Journal of Cancer, 44, 75-80.
30. Fairbanks, V.F., Maldonado, J.E., Charache, S. & Boyer, S.H. IV. (1971) Familial erythrocytosis due to electrophoretically undetectable hemoglobin with impaired oxygen dissociation (hemoglobin Malmo, alpha 2 beta 2 97 gln). Mayo Clinic Proceedings, 46, 721-727.
31. Faurschou, M., Nielsen, O.J., Jensen, M.K. & Hasselbalch, H.C. (2000) High prevalence of hyperhomocysteinemia due to marginal deficiency of cobalamin or folate in chronic myeloproliferative disorders. American Journal of Hematology, 65, 136-140.
32. Foa, P., Massaro, P., Caldiera, S., LaTargia, M.L., Iurlo, A., Clerici, C., Fornier, M., Bertoni, F. & Maiolo, A.T. (1998) Long-term therapeutic efficacy and toxicity of recombinant interferon-alpha 2a in polycythaemia vera. European Journal of Haematology, 60, 273-277.
33. Fruchtman, S.M., Mack, K., Kaplan, M.E., Peterson, P., Berk, P.D. & Wasserman, L.R. (1997) From efficacy to safety: a Polycythemia Vera Study group report on hydroxyurea in patients with polycythemia vera. Seminars in Hematology, 34, 17-23.
34. Gaston, R.S., Julian, B.A. & Curtis, J.J. (1994) Posttransplant erythrocytosis: an enigma revisited. American Journal of Kidney Diseases, 24, 1-11.
35. van Genderen, P.J., Michiels, J.J., van Strik, R., Lindemans, J. & van Vliet, H.H. (1995) Platelet consumption in thrombocythemia complicated by erythromelalgia: reversal by aspirin. Thrombosis and Haemostasis, 73, 210-214.
36. Gidding, S.S. & Stockman, J.A. III. (1988) Effect of iron deficiency on tissue oxygen delivery in cyanotic congenital heart disease. The American Journal of Cardiology, 61, 605-607.
37. Grace, R.J., Gover, P.A., Treacher, D.F., Heard, S.E. & Pearson, T.C. (1992) Venesection in haemoglobin Yakima, a high oxygen affinity haemoglobin. Clinical and Laboratory Haematology, 14, 195-199.
38. Greaves, M., Cohen, H., MacHin, S.J. & Mackie, I. (2000) Guidelines on the investigation and management of the antiphospholipid syndrome. British Journal of Haematology, 109, 704-715.
39. Griesshammer, M., Bergmann, L. & Pearson, T. (1998) Fertility, pregnancy and the management of myeloproliferative disorders. Bailliere's Clinical Haematology, 11, 859-874.
40. Gruppo Italiano Studio Policitemia (GISP) (1995) Polycythaemia vera: The National History of 1213 patients followed for 20 years. Annals of Internal Medicine, 123, 656-664.
41. Gruppo Italiano Studio Policitemia (1997) Low-dose aspirin in polycythaemia vera: a pilot study. British Journal of Haematology, 97, 453-456.
42. Guthrie, D.L. & Pearson, T.C. (1982) PCV measurement in the management of polycythaemic patients. Clinical and Laboratory Haematology, 4, 257-265.
43. Haemostasis and Thrombosis Task Force, British Committee for Standards in Haematology (2001) Investigation and management of heritable thrombophilia. British Journal of Haematology, 114, 512-528.
44. Halsey, C. & Roberts, I.A. (2003) The role of hydroxyurea in sickle cell disease. British Journal of Haematology, 120, 177-186.
45. Hanft, V.N., Fruchtman, S.R., Pickens, C.V., Rosse, W.F., Howard, T.A. & Ware, R.E. (2000) Acquired DNA mutations associated with in vivo hydroxyurea exposure. Blood, 95, 3589-3593.
46. Hanss, M., Lacan, P., Aubry, M., Lienhard, A. & Francina, A. (2002) Thrombotic events in compound heterozygotes for a high affinity hemoglobin variant: Hb Milledgeville [alpha44(CE2)Pro → Leu (alpha2)] and factor V Leiden. Hemoglobin, 26, 285-290.
47. Harrison, C.N. (2002) Current trends in essential thrombocythaemia. British Journal of Haematology, 117, 796-808.
48. Harrison, B.D. & Stokes, T.C. (1982) Secondary polycythaemia: its causes, effects and treatment. British Journal of Diseases of the Chest, 76, 313-340.
49. Harrison, B.D., Davis, J., Madgwick, R.G. & Evans, M. (1973) The effects of therapeutic decrease in packed cell volume on the responses to exercise of patients with polycythaemia secondary to lung disease. Clinical Science and Molecular Medicine, 45, 833-847.
50. Heis, N., Rintelen, C., Gisslinger, B., Knobl, P., Lechner, K. & Gisslinger, H. (1999) The effect of interferon alpha on myeloproliferation and vascular complications in polycythemia vera. European Journal of Haematology, 62, 27-31.
51. Higuchi, T., Okada, S., Mori, H., Niikura, H., Omine, M. & Terada, H. (1995) Leukemic transformation of polycythemia vera and essential thrombocythemia possibly associated with an alkylating agent. Cancer, 75, 471-477.
52. Humphrey, P.R., Michael, J. & Pearson, T.C. (1980) Red cell mass, plasma volume and blood volume before and after venesection in relative polycythaemia. British Journal of Haematology, 46, 435-438.
53. Hunt, B.J., Gattens, M., Khamashta, M., Nelson-Piercy, C. & Almeida, A. (2003) Thromboprophylaxis with unmonitored intermediate-dose low molecular weight heparin in pregnancies with a previous arterial or venous thrombotic event. Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis, 14, 735-739.
54. Hutton, R.D. (1979) The effect of iron deficiency on whole blood viscosity in polycythaemic patients. British Journal of Haematology, 43, 191-199.
55. Imbert, M., Pierre, R., Thiele, J., Vardiman, J.W., Brunning, R.D. & Flandrin, G. (2001) Essential Thrombocythaemia. In: Tumours of Haematopoietic and Lymphoid Tissues (ed. by E.S. Jaffe, H.L. Harris, H. Stein & J.W. Vardiman), pp. 39-41. IARC Press, Lyon.
56. International Committee for Standardization in Haematology (1980) Recommended methods for measurement of red-cell and plasma volume. Journal of Nuclear Medicine, 21, 793-800.
57. Jackson, N., Shukri, A. & Ali, K. (1993) Hydroxyurea treatment for chronic myeloid leukaemia during pregnancy. British Journal of Haematology, 85, 203-204.
58. Jeanmougin, M., Rain, J.D. & Najean, Y. (1996) Efficacy of photochemotherapy on severe pruritus in polycythemia vera. Annals of Hematology, 73, 91-93.
59. Jenkinson, C., Davies, R.J., Mullins, R. & Stradling, J.R. (1999) Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised prospective parallel trial. Lancet, 353, 2100-2105.
60. Johns, M.W. (1993) Daytime sleepiness, snoring, and obstructive sleep apnea. The Epworth Sleepiness Scale. Chest, 103, 30-36.
61. Julian, B.A., Brantley, R.R. Jr, Barker, C.V., Stopka, T., Gaston, R.S., Curtis, J.J., Lee, J.Y. & Prchal, J.T. (1998) Losartan, an angiotensin II type 1 receptor antagonist, lowers hematocrit in posttransplant erythrocytosis. Journal of the American Society of Nephrology, 9, 1104-1108.
62. Kaboth, U., Rumpf, K.W., Liersch, T., Vehmeyer, K., Krieter, D. & Kaboth, W. (1997) Advantages of isovolemic large-volume erythrocytapheresis as a rapidly effective and long-lasting treatment modality for red blood cell depletion in patients with polycythemia vera. Therapeutic Apheresis, 1, 131-134.
63. Kaplan, M.E., Mack, K., Goldberg, J.D., Donovan, P.B., Berk, P.D. & Wasserman, L.R. (1986) Long-term management of polycythemia vera with hydroxyurea: a progress report. Seminars in Hematology, 23, 167-171.
64. Kelman, C.W., Kortt, M.A., Becker, N.G., Li, Z., Mathews, J.D., Guest, C.S. & Holman, C.D. (2003) Deep vein thrombosis and air travel: record linkage study. British Medical Journal, 327, 1072.
65. Kiladjian, J.J., Gardin, C., Renoux, M., Bruno, F. & Bernard, J.F. (2003) Long-term outcomes of polycythemia vera patients treated with pipobroman as initial therapy. Hematology Journal, 4, 198-207.
66. Kralovics, R., Buser, A.S., Teo, S.S., Goers, J., Tichelli, A., van der Maas, A.P. & Skoda, R.C. (2003) Comparison of molecular markers in a cohort of patients with chronic myeloproliferative disorders. Blood, 102, 1869-1871.
67. Kurita, S. (1974) [Epidemiological studies of polycythemia vera in Japan (author's transl)]. Nippon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society, 37, 793-795.
68. Kutti, J. & Ridell, B. (2001) Epidemiology of the myeloproliferative disorders: essential thrombocythaemia, polycythaemia vera and idiopathic myelofibrosis. Pathologie-Biologie, 49, 164-166.
69. Landolfi, R., Marchioli, R., Kutti, J., Gisslinger, H., Tognoni, G., Patrono, C., Barbui, T. & European Collaboration on Low-Dose Aspirin in Polycythemia Vera Investigators. (2004) Efficacy and safety of low-dose aspirin in polycythemia vera. The New England Journal of Medicine, 350, 114-124.
70. Larson, P.J., Friedman, D.F., Reilly, M.P., Kattamis, A.C., Asakura, T., Fortina, P., Cohen, A.R., Kim, H.C. & Manno, C.S. (1997) The presurgical management with erythrocytapheresis of a patient with a high-oxygen-affinity, unstable Hb variant (Hb Bryn Mawr). Transfusion, 37, 703-707.
71. Lawrence, J.H. (1940) Preliminary Report on a new treatment for the treatment of leukaemia and polycythaemia radiology. Nuclear Physics and Therapy, 35, 51-59.
72. Linderkamp, O., Klose, H.J., Betke, K., Brodherr-Heberlein, S., Buhlmeyer, K., Kelson, S. & Sengespeik, C. (1979) Increased blood viscosity in patients with cyanotic congenital heart disease and iron deficiency. The Journal of Pediatrics, 95, 567-569.
73. Logue, G.L., Gutterman, J.U., McGinn, T.G., Laszlo, J. & Rundles, R.W. (1970) Melphalan therapy of polycythemia vera. Blood, 36, 70-86.
74. Lowe, G.D. (1999) Rheological influences on thrombosis. Bailliere's Best Practice & Research. Clinical Haematology, 12, 435-449.
75. Menon, D., York, E.L., Bornstein, R.A., Jones, R.L. & Sproule, B.J. (1981) Optimal hematocrit and blood viscosity in secondary polycythemia as determined from cerebral blood flow. Clinical and Investigative Medicine. Medecine Clinique Et Experimentale, 4, 117-121.
76. Messinezy, M. & Pearson, T.C. (1990) A retrospective study of apparent and relative polycythaemia: associated factors and early outcome. Clinical and Laboratory Haematology, 12, 121-129.
77. Messinezy, M., Pearson, T.C., Prochazka, A. & Wetherley-Mein, G. (1985) Treatment of primary proliferative polycythaemia by venesection and low dose busulphan: retrospective study from one centre. British Journal of Haematology, 61, 657-666.
78. Messinezy, M., Macdonald, L.M., Nunan, T.O., Westwood, N.B., Chinn, S. & Pearson, T.C. (1997) Spleen sizing by ultrasound in polycythaemia and thrombocythaemia: comparison with SPECT. British Journal of Haematology, 98, 103-107.
79. Messinezy, M., Westwood, N.B., El-Hemaidi, I., Marsden, J.T., Sherwood, R.S. & Pearson, T.C. (2002a) Serum erythropoietin values in erythrocytoses and in primary thrombocythaemia. British Journal of Haematology, 117, 47-53.
80. Messinezy, M., Westwood, N.B., El-Hemaidi, I., Marsden, J.T., Sherwood, R.S. & Pearson, T.C. (2002b) Serum erythropoietin values in erythrocytoses and in primary thrombocythaemia. British Journal of Haematology, 117, 47-53.
81. Milligan, D.W., Thein, S.L. & Roberts, B.E. (1982) Secondary treatment of polycythemia rubra vera with 6-thioguanine. Cancer, 50, 836-839.
82. Modan, B. & Modan, M. (1968) Benign erythrocytosis. British Journal of Haematology, 14, 375-381.
83. Moore-Gillon, J.C., Treacher, D.F., Gaminara, E.J., Pearson, T.C. & Cameron, I.R. (1986) Intermittent hypoxia in patients with unexplained polycythaemia. British Medical Journal, 293, 588-590.
84. 32P alone or in combination with maintenance therapy using hydroxyurea in 461 patients greater than 65 years of age. The French Polycythemia Study Group. Blood, 89, 2319-2327.
85. Najean, Y. & Rain, J.D. (1997b) Treatment of polycythemia vera: the use of hydroxyurea and pipobroman in 292 patients under the age of 65 years. Blood, 90, 3370-3377.
86. Najean, Y., Triebel, F. & Dresch, C. (1981) Pure erythrocytosis: reappraisal of a study of 51 cases. American Journal of Hematology, 10, 129-136.
87. Najean, Y., Dresch, C. & Rain, J.D. (1994) The very-long-term course of polycythaemia: a complement to the previously published data of the Polycythaemia Vera Study Group. British Journal of Haematology, 86, 233-235.
88. Nurden, P., Bihour, C., Smith, M., Raymond, J.M. & Nurden, A.T. (1996) Platelet activation and thrombosis: studies in a patient with essential thrombocythemia. American Journal of Hematology, 51, 79-84.
89. Oldershaw, P.J. & Sutton, M.G. (1980) Haemodynamic effects of haematocrit reduction in patients with polycythaemia secondary to cyanotic congenital heart disease. British Heart Journal, 44, 584-588.
90. Oren, R., Beeri, M., Hubert, A., Kramer, M.R. & Matzner, Y. (1997) Effect of theophylline on erythrocytosis in chronic obstructive pulmonary disease. Archives of Internal Medicine, 157, 1474-1478.
91. Osgood, E.E. (1964) Contrasting incidence of acute monocytic and granulocytic leukemias in p32 treated patients with polycythemia vera and chronic lymphocytic leukemia. Journal of Laboratory and Clinical Medicine, 64, 560-573.
92. Partanen, S., Juvonen, E., Ikkala, E. & Ruutu, T. (1989) Spontaneous erythroid colony formation in the differential diagnosis of erythrocytosis. European Journal of Haematology, 42, 327-330.
93. Patel, M., Dukes, I.A. & Hull, J.C. (1991) Use of hydroxyurea in chronic myeloid leukemia during pregnancy: a case report. American Journal of Obstetrics and Gynecology, 165, 565-566.
94. Pearson, T.C. (1991) Apparent polycythaemia. Blood Reviews, 5, 205-213.
95. Pearson, T.C. (2001) Hemorheology in the erythrocytoses. The Mount Sinai Journal of Medicine, New York, 68, 182-191.
96. Pearson, T.C. & Messinezy, M. (1996) The diagnostic criteria of polycythaemia rubra vera. Leukemia & Lymphoma, 22 (Suppl. 1), 87-93.
97. Pearson, T.C. & Treacher, D.F. (1990) Polycythaemia in systemic disease. In: Haematological Aspects of Systemic Disease (ed. by I.W. Delamore & J.A. Liu Yin), pp. 67-120. Balliere Tindall, London.
98. Pearson, T.C. & Wetherley-Mein, G. (1978) Vascular occlusive episodes and venous haematocrit in primary proliferative polycythaemia. Lancet, 2, 1219-1222.
99. Pearson, T.C. & Wetherley-Mein, G. (1979) The course and complications of idiopathic erythrocytosis. Clinical and Laboratory Haematology, 1, 189-196.
100. Pearson, T.C., Guthrie, D.L., Simpson, J., Chinn, S., Barosi, G., Ferrant, A., Lewis, S.M. & Najean, Y. (1995) Interpretation of measured red cell mass and plasma volume in adults: Expert Panel on Radionuclides of the International Council for Standardization in Haematology. British Journal of Haematology, 89, 748-756.
101. Pengelly, C.D. (1966) Reduction of haematocrit and red-blood-cell volume in patients with polycythaemia secondary to hypoxic lung disease by dapsone and pyrimethamine. Lancet, 2, 1381-1386.
102. Percy, M.J., McMullin, M.F., Roques, A.W., Westwood, N.B., Acharya, J., Hughes, A.E., Lappin, T.R. & Pearson, T.C. (1998) Erythrocytosis due to a mutation in the erythropoietin receptor gene. British Journal of Haematology, 100, 407-410.
103. Percy, M.J., McMullin, M.F., Jowitt, S.N., Potter, M., Treacy, M., Watson, W.H. & Lappin, T.R. (2003) Chuvash-type congenital polycythemia in 4 families of Asian and Western European ancestry. Blood, 102, 1097-1099.
104. Perloff, J.K., Rosove, M.H., Child, J.S. & Wright, G.B. (1988) Adults with cyanotic congenital heart disease: hematologic management. Annals of Internal Medicine, 109, 406-413.
105. Perloff, J.K., Marelli, A.J. & Miner, P.D. (1993) Risk of stroke in adults with cyanotic congenital heart disease. Circulation, 87, 1954-1959.
106. Phornphutkul, C., Rosenthal, A., Nadas, A.S. & Berenberg, W. (1973) Cerebrovascular accidents in infants and children with cyanotic congenital heart disease. The American Journal of Cardiology, 32, 329-334.
107. Pierre, R., Imbert, M., Thiele, J., Vardiman, J.W., Brunning, R.D. & Flandrin, G. (2001) Polycythaemia Vera. In: Tumours of Haematopoietic and Lymphoid Tissues (ed. by E.S. Jaffe, H.L. Harris, H. Stein & J.W. Vardiman), pp. 32-34. IARC Press, London.
108. Rai, R., Cohen, H., Dave, M. & Regan, L. (1997) Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). British Medical Journal, 314, 253-257.
109. Rich, A.R. (1948) A hitherto unrecognised tendency to the development of widespread pulmonary vascular obstruction in adults with congenital pulmonary stenosis (Tetralogy of Fallot). Bulletin of Johns Hopkins Hospital, 82, 389-395.
110. Robinson, S.E., Radia, D., Pocock, M., Duncan, J., Mumford, A., Machin, S., Bewley, S., Hunt, B.J. & Harrison, C. (2004) Polycythaemia and pregnancy: a review of treatment and outcome of 16 pregnancies in 8 women. British Journal of Haematology, 125, 66.
111. Rosenthal, E. & Anderson, D. (1998) Inappropriate management of polycythaemia in adults with cyanotic congenital heart disease. Heart, 80, 532.
112. Rosenthal, A., Nathan, D.G., Marty, A.T., Button, L.N., Miettinen, O.S. & Nadas, A.S. (1970) Acute hemodynamic effects of red cell volume reduction in polycythemia of cyanotic congenital heart disease. Circulation, 42, 297-308.
113. Rosove, M.H., Perloff, J.K., Hocking, W.G., Child, J.S., Canobbio, M.M. & Skorton, D.J. (1986) Chronic hypoxaemia and decompensated erythrocytosis in cyanotic congenital heart disease. Lancet, 2, 313-315.
114. Rostaing, L., Boisseau, M., Huyn, A. & Durand, D. (1995) Correction of post-renal transplant erythrocytosis by enalapril. Scandinavian Journal of Urology and Nephrology, 29, 399-406.
115. Ruggeri, M., Gisslinger, H., Tosetto, A., Rintelen, C., Mannhalter, C., Pabinger, I., Heis, N., Castaman, G., Missiaglia, E., Lechner, K. & Rodeghiero, F. (2002) Factor V Leiden mutation carriership and venous thromboembolism in polycythemia vera and essential thrombocythemia. American Journal of Hematology, 71, 1-6.
116. Salem, H.H., Van der Weyden, M.B., Young, L.F. & Wiley, J.S. (1982) Pruritus and severe iron deficiency in polycythaemia vera. British Medical Journal, 285, 91-92.
117. Sanson, B.J., Lensing, A.W., Prins, M.H., Ginsberg, J.S., Barkagan, Z.S., Lavenne-Pardonge, E., Brenner, B., Dulitzky, M., Nielsen, J.D., Boda, Z., Turi, S., Mac Gillavry, M.R., Hamulyak, K., Theunissen, I.M., Hunt, B.J. & Buller, H.R. (1999) Safety of low-molecular-weight heparin in pregnancy: a systematic review. Thrombosis and Haemostasis, 81, 668-672.
118. Segel, N. & Bishop, J.M. (1966) The circulation in patients with chronic bronchitis and emphysema at rest and during exercise, with special reference to the influence of changes in blood viscosity and blood volume on the pulmonary circulation. The Journal of Clinical Investigation, 45, 1555-1568.
119. Simonds, A.K. & Elliott, M.W. (1995) Outcome of domiciliary nasal intermittent positive pressure ventilation in restrictive and obstructive disorders. Thorax, 50, 604-609.
120. Smith, J.R. & Landaw, S.A. (1978) Smokers' polycythemia. The New England Journal of Medicine, 298, 6-10.
121. Somerville, J. (1997) Management of adults with congenital heart disease: an increasing problem. Annual Review of Medicine, 48, 283-293.
122. Sondel, P.M., Tripp, M.E., Ganick, D.J., Levy, J.M. & Shahidi, N.T. (1981) Phlebotomy with iron therapy to correct the microcytic polycythemia of chronic hypoxia. Pediatrics, 67, 667-670.
123. Spivak, J.L. (2002) The optimal management of polycythaemia vera. British Journal of Haematology, 116, 243-254.
124. Sterkers, Y., Preudhomme, C., Lai, J.L., Demory, J.L., Caulier, M.T., Wattel, E., Bordessoule, D., Bauters, F. & Fenaux, P. (1998) Acute myeloid leukemia and myelodysplastic syndromes following essential thrombocythemia treated with hydroxyurea: high proportion of cases with 17p deletion. Blood, 91, 616-622.
125. Tartaglia, A.P., Goldberg, J.D., Berk, P.D. & Wasserman, L.R. (1986) Adverse effects of antiaggregating platelet therapy in the treatment of polycythemia vera. Seminars in Hematology, 23, 172-176.
126. Tatarsky, I. & Sharon, R. (1997) Management of polycythemia vera with hydroxyurea. Seminars in Hematology, 34, 24-28.
127. Taylor, P.C., Dolan, G., Ng, J.P., Paul, B., Collin, R. & Reilly, J.T. (1996) Efficacy of recombinant interferon-alpha (rIFN-alpha) in polycythaemia vera: a study of 17 patients and an analysis of published data. British Journal of Haematology, 92, 55-59.
128. Tefferi, A. & Fonseca, R. (2002) Selective serotonin reuptake inhibitors are effective in the treatment of polycythemia vera-associated pruritus. Blood, 99, 2627.
129. Terasako, K. & Sasai, S. (1998) Platelet transfusion for surgery in the presence of polycythemia vera. Acta Anaesthesiologica Scandinavica, 42, 270-271.
130. Territo, M.C. & Rosove, M.H. (1991) Cyanotic congenital heart disease: hematologic management. Journal of the American College of Cardiology, 18, 320-322.
131. Thiele, J., Kvasnicka, H.M., Zankovich, R. & Diehl, V. (2001a) The value of bone marrow histology in differentiating between early stage Polycythemia vera and secondary (reactive) Polycythemias. Haematologica, 86, 368-374.
132. Thiele, J., Pierie, R., Imbert, M., Vaardinian, J.W., Brunning, R.D. & Flandrin, V. (2001b) Chronic Idiopathic Myelofibrosis. In: Tumours of Haematopoietic and Lymphoid Tissues (ed. by E.S. Jaffe, H.L. Harris, H. Stein & J.W. Vardinian), pp. 35-38. IARC Press, Lyon.
133. Thomas, D.J., du Boulay, G.H., Marshall, J., Pearson, T.C., Ross Russell, R.W., Symon, L., Wetherley-Mein, G. & Zilkha, E. (1977) Cerebral blood-flow in polycythaemia. Lancet, 2, 161-163.
134. Thorne, S.A. (1998) Management of polycythaemia in adults with cyanotic congenital heart disease. Heart, 79, 315-316.
135. Van de Pette, J.E., Guthrie, D.L. & Pearson, T.C. (1986) Whole blood viscosity in polycythaemia: the effect of iron deficiency at a range of haemoglobin and packed cell volumes. British Journal of Haematology, 63, 369-375.
136. Vlahakos, D.V., Kosmas, E.N., Dimopoulou, I., Ikonomou, E., Jullien, G., Vassilakos, P. & Marathias, K.P. (1999) Association between activation of the renin-angiotensin system and secondary erythrocytosis in patients with chronic obstructive pulmonary disease. The American Journal of Medicine, 106, 158-164.
137. Vlahakos, D.V., Marathias, K.P., Agroyannis, B. & Madias, N.E. (2003) Posttransplant erythrocytosis. Kidney International, 63, 1187-1194.
138. Wade, J.P., Pearson, T.C., Russell, R.W. & Wetherley-Mein, G. (1981) Cerebral blood flow and blood viscosity in patients with polycythaemia secondary to hypoxic lung disease. British Medical Journal, 283, 689-692.
139. Wasserman, L.R. & Gilbert, H.S. (1964) Surgical Bleeding in Polycythaemia Vera. Annals of the New York Academy of Sciences, 115, 122-138.
140. Weatherall, D.J., Clegg, J.B., Callender, S.T., Wells, R.M., Gale, R.E., Huehns, E.R., Perutz, M.F., Viggiano, G. & Ho, C. (1977) Haemoglobin Radcliffe (alpha2beta299(Gi)Ala): a high oxygen-affinity variant causing familial polycythaemia. British Journal of Haematology, 35, 177-191.
141. Wedemeyer, A.L. & Lewis, J.H. (1973) Improvement in hemostasis following phlebotomy in cyanotic patients with heart disease. The Journal of Pediatrics, 83, 46-50.
142. Wedzicha, J.A., Rudd, R.M., Apps, M.C., Cotter, P.E., Newland, A.C. & Empey, D.W. (1983) Erythrapheresis in patients with polycythaemia secondary to hypoxic lung disease. British Medical Journal, 286, 511-514.
143. Weick, J.K., Donovan, P.B., Najean, Y., Dresch, C., Pisciotta, A.V., Cooperberg, A.A. & Goldberg, J.D. (1982) The use of cimetidine for the treatment of pruritus in polycythemia vera. Archives of Internal Medicine, 142, 241-242.
144. Weinfeld, A., Swolin, B. & Westin, J. (1994) Acute leukaemia after hydroxyurea therapy in polycythaemia vera and allied disorders: prospective study of efficacy and leukaemogenicity with therapeutic implications. European Journal of Haematology, 52, 134-139.
145. Weinreb, N.J. & Shih, G.F. (1975) Spurious polycythemia. Seminars in Hematology, 12, 397-407.
146. Weisse, A.B., Moschos, C.B., Frank, M.J., Levinson, G.E., Cannilla, J.E. & Regan, T.J. (1975) Hemodynamic effects of staged hematocrit reduction in patients with stable cor pulmonale and severely elevated hematocrit levels. The American Journal of Medicine, 58, 92-98.
147. Whitehead, T.P., Robinson, D., Allaway, S.L. & Hale, A.C. (1995) The effects of cigarette smoking and alcohol consumption on blood haemoglobin, erythrocytes and leucocytes: a dose related study on male subjects. Clinical and Laboratory Haematology, 17, 131-138.
148. Wickre, C.G., Norman, D.J., Bennison, A., Barry, J.M. & Bennett, W.M. (1983) Postrenal transplant erythrocytosis: a review of 53 patients. Kidney International, 23, 731-737.
149. Winslow, R.M., Butler, W.M., Kark, J.A., Klein, H.G. & Moo-Penn, W. (1983) The effect of bloodletting on exercise performance in a subject with a high-affinity hemoglobin variant. Blood, 62, 1159-1164.
150. Yeager, S.B. & Freed, M.D. (1984) Myocardial infarction as a manifestation of polycythemia in cyanotic heart disease. The American Journal of Cardiology, 53, 952-953.
151. Yusuf, S., Zhao, F., Mehta, S.R., Chrolavicius, S., Tognoni, G., Fox, K.K. & Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. (2001) Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. The New England Journal of Medicine, 345, 494-502.